Multiple Sclerosis
NYU Langone tops list again as best US hospital for neurology, neurosurgery
NYU Langone was again the top hospital in the United States for neurology and neurosurgery, according to the latest annual Best Hospitals Survey issued by U.S. News & World Report.
In $185M deal, Merz purchases Parkinson’s, MS therapeutics from Acorda
Merz Therapeutics announced that it has acquired assets from Acorda Therapeutics Inc. in development to treat Parkinson’s disease and multiple sclerosis.
European Commission authorizes subcutaneous Ocrevus for multiple sclerosis
The European Commission has authorized a subcutaneous injection of Ocrevus to treat relapsing multiple sclerosis as well as primary progressive MS, according to the manufacturer.
Labcorp, Quest Diagnostics add to roster of blood-based biomarker testing for Alzheimer’s
Labcorp and Quest Diagnostics have both announced the availability of blood-based biomarker testing for Alzheimer’s disease, one which detects glial fibrillary acidic protein and another for phosphorylated tau.
Climate change linked with increases in autoimmune diseases
The effects of climate change break down epithelial barriers, enabling pollutants and other materials to penetrate the body and trigger or exacerbate autoimmune diseases, according to a review published in Frontiers in Science.
VIDEO: Study characterizes patients with MS seeking treatment for cannabis use disorder
DENVER — Researchers have recruited women with multiple sclerosis for a study using a home-based telehealth intervention for cannabis use disorder, according to a poster presented at the American Academy of Neurology annual meeting.
Multiple Sclerosis Awareness Month: Latest research, treatments from ACTRIMS 2024
March is Multiple Sclerosis Awareness Month, a time to improve knowledge of and highlight the growing treatment options for progressive types of this degenerative disease.
Obesity linked to disability worsening, declining quality of life in MS
WEST PALM BEACH, Fla. — Obesity was strongly associated with disability worsening, disease progression and declining quality of life in a cohort of adults diagnosed with multiple sclerosis, according to a presenter at ACTRIMS 2024.
FDA rejects new drug application for intramuscular MS treatment
The FDA has declined to approve a new drug application for GA Depot 40 mg, a long-acting glatiramer acetate under investigation as a once-monthly injection for those with relapsing forms of multiple sclerosis, according to a press release
VIDEO: ‘Optimally personalize’ care to safely target extraintestinal manifestations of IBD
In a Healio video exclusive, Gil Y. Melmed, MD, MS, highlights certain therapies that should be avoided or included in the management of patients with extraintestinal manifestations of inflammatory bowel disease.